Literature DB >> 12928304

Does topical brimonidine tartrate help NAION?

H E Fazzone, M J Kupersmith, J Leibmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12928304      PMCID： PMC1771838          DOI： 10.1136/bjo.87.9.1193

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Potential effects of common drugs on stroke recovery.

Authors:  L B Goldstein
Journal:  Arch Neurol       Date:  1998-04

2.  Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.

Authors:  E WoldeMussie; G Ruiz; M Wijono; L A Wheeler
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-11       Impact factor: 4.799

3.  Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.

Authors:  L A Wheeler; E Woldemussie
Journal:  Eur J Ophthalmol       Date:  2001 Jul-Sep       Impact factor: 2.597

4.  Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.

Authors:  L A Wheeler; D W Gil; E WoldeMussie
Journal:  Surv Ophthalmol       Date:  2001-05       Impact factor: 6.048

5.  Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.

Authors:  E Yoles; L A Wheeler; M Schwartz
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799
  5 in total
  11 in total

1.  Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial.

Authors:  Barbara Wilhelm; Holger Lüdtke; Helmut Wilhelm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-08       Impact factor: 3.117

2.  Increased relative mitochondrial DNA content in leucocytes of patients with NAION.

Authors:  K K Abu-Amero; T M Bosley
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

3.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

4.  Randomized Controlled Phase 2a Study of RPh201 in Previous Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Eitan Z Rath; Zadik Hazan; Konstantin Adamsky; Arieh Solomon; Zvi I Segal; Leonard A Levin
Journal:  J Neuroophthalmol       Date:  2019-09       Impact factor: 3.042

Review 5.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

6.  Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation.

Authors:  Cynthia A Gossman; David M Linn; Cindy Linn
Journal:  J Vis Exp       Date:  2016-03-12       Impact factor: 1.355

Review 7.  Efficacy of granulocyte-colony stimulating factor treatment in a rat model of anterior ischemic optic neuropathy.

Authors:  Shun-Ping Huang; Rong-Kung Tsai
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

8.  Estrogen is not neuroprotective in a rodent model of optic nerve stroke.

Authors:  Steven L Bernstein; Zara Mehrabyan; Yan Guo; Nima Moianie
Journal:  Mol Vis       Date:  2007-10-09       Impact factor: 2.367

9.  Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy - retrospective analysis.

Authors:  Michael Kinori; Iris Ben-Bassat; Yael Wasserzug; Angela Chetrit; Ruth Huna-Baron
Journal:  BMC Ophthalmol       Date:  2014-05-03       Impact factor: 2.209

Review 10.  Translational Preclinical Research may Lead to Improved Medical Management of Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  James D Nicholson; Hana Leiba; Nitza Goldenberg-Cohen
Journal:  Front Neurol       Date:  2014-07-11       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.